NO961685L - Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom - Google Patents
Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdomInfo
- Publication number
- NO961685L NO961685L NO961685A NO961685A NO961685L NO 961685 L NO961685 L NO 961685L NO 961685 A NO961685 A NO 961685A NO 961685 A NO961685 A NO 961685A NO 961685 L NO961685 L NO 961685L
- Authority
- NO
- Norway
- Prior art keywords
- carriers
- minimal disease
- thymosin
- treating hepatitis
- subject
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000036141 Viral hepatitis carrier Diseases 0.000 title 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 abstract 2
- 108010046075 Thymosin Proteins 0.000 abstract 1
- 102000007501 Thymosin Human genes 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/833,468 US5308833A (en) | 1992-02-06 | 1992-02-06 | Method for treating hepatitis B carriers with minimal disease |
| PCT/US1993/010343 WO1995011688A1 (en) | 1992-02-06 | 1993-10-28 | Method for treating hepatitis b carriers with minimal disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961685D0 NO961685D0 (no) | 1996-04-26 |
| NO961685L true NO961685L (no) | 1996-04-26 |
Family
ID=1340654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961685A NO961685L (no) | 1992-02-06 | 1996-04-26 | Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0728010A4 (enrdf_load_stackoverflow) |
| NO (1) | NO961685L (enrdf_load_stackoverflow) |
| SG (1) | SG64892A1 (enrdf_load_stackoverflow) |
| TW (1) | TW249755B (enrdf_load_stackoverflow) |
| WO (1) | WO1995011688A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0731710B1 (en) * | 1993-11-05 | 2003-05-14 | Alpha 1 Biomedicals, Inc. | Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4079127A (en) * | 1976-10-28 | 1978-03-14 | Board Of Regents Of The University Of Texas | Thymosin alpha 1 |
| TW224053B (enrdf_load_stackoverflow) * | 1991-09-13 | 1994-05-21 | Paul B Chretien | |
| US5308833A (en) * | 1992-02-06 | 1994-05-03 | Sciclone Pharmaceuticals | Method for treating hepatitis B carriers with minimal disease |
-
1993
- 1993-10-28 EP EP93925097A patent/EP0728010A4/en not_active Withdrawn
- 1993-10-28 SG SG1996005575A patent/SG64892A1/en unknown
- 1993-10-28 WO PCT/US1993/010343 patent/WO1995011688A1/en not_active Application Discontinuation
- 1993-11-02 TW TW82109202A patent/TW249755B/zh active
-
1996
- 1996-04-26 NO NO961685A patent/NO961685L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0728010A4 (en) | 1997-10-01 |
| NO961685D0 (no) | 1996-04-26 |
| TW249755B (enrdf_load_stackoverflow) | 1995-06-21 |
| EP0728010A1 (en) | 1996-08-28 |
| WO1995011688A1 (en) | 1995-05-04 |
| SG64892A1 (en) | 1999-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800674A1 (ru) | Способ повторного лечения больных гепатитом с | |
| ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
| DK0597033T3 (da) | IGF-1 til forbedring af den neurale tilstand | |
| DK0662157T3 (da) | Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme | |
| HU883981D0 (en) | Process for the production of medical preparations with antiviral or antibacterial effect | |
| RU2002130192A (ru) | Способ лечения или предупреждения ожирения | |
| GR3015302T3 (en) | Pharmaceutical formulations for preventing drug tolerance. | |
| NO940564D0 (no) | Ny fremgangsmåte for fremstilling av Cetrorelixlyofilisat | |
| DK0817646T3 (da) | Fremgangsmåder til behandling af inflammation og præparater derfor | |
| KR960705578A (ko) | 경증 질환을 가진 b형 간염 보균자의 치료방법(method for treating hepatitis b carriers with minimal disease) | |
| NO961685L (no) | Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom | |
| RU93033683A (ru) | Способ лечения язвенной болезни двенадцатиперстной кишки | |
| RU2003100517A (ru) | Новый интерферон для лечения рассеянного склероза | |
| YU56702A (sh) | Korišćenje fsh za lečenje neplodnosti | |
| NO950599L (no) | Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4 | |
| MY137298A (en) | Therapeutic nucleosides | |
| OA08768A (fr) | Traitement du virus su SIDA par l'interféron alpha humain recombinant. | |
| DK1007085T3 (da) | Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet | |
| MY109685A (en) | Method for treating hepatitis b carriers with minimal disease | |
| DK0556051T3 (da) | Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse. | |
| UA26326C2 (uk) | Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації | |
| TH15542A (th) | วิธีสำหรับรักษาผู้เป็นพาหะของเฮพาไททิสบี ที่มีอาการของโรคต่ำสุด | |
| Lim et al. | EVIDENCE FOR HE CHANGES IN THE DOPAMINERGIC ACTIVITY AFTER THE SUBACUTE ADMINSTRATION WITH PHYSOSTIGMINE | |
| DE60121449D1 (de) | Behandlung von hepatitis c mit thymosin und pegyliertem interferon | |
| RU97105771A (ru) | Способ лечения сахарного диабета |